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Olle Ljungqvist3
Received: 25 January 2016 / Accepted: 31 January 2016 / Published online: 12 February 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract There is evidence that implementation of
enhanced recovery after surgery (ERAS) protocols into
colorectal surgery reduces complication rate and improves
postoperative recovery. However, most published papers
on ERAS outcomes and length of stay in hospital (LOS)
include patients undergoing open resections. The aim of
this pilot study was to determine the factors affecting
recovery and LOS in patients after laparoscopic colorectal
surgery for cancer combined with ERAS protocol. One
hundred and forty-three consecutive patients undergoing
elective laparoscopic resection were prospectively evalu-
ated. They were divided into two subgroups depending on
their reaching the targeted length of stay—LOS (75
patients in group 1—B4 days, 68 patients in group 2—
[4 days). A univariate and multivariate logistic regression
analysis was performed to assess for factors (demograph-
ics, perioperative parameters, complications and compli-
ance with the ERAS protocol) independently associated
with LOS of 4 days or longer. The median LOS in the
entire group was 4 days. The postoperative complication
rate was higher (18.7 vs. 36.7 %), and the compliance with
ERAS protocol was lower (91.2 vs. 76.7 %) in group 2.
There was an association between the pre- and postopera-
tive compliance and the subsequent complications. In uni-
and multivariate analysis, the lack of balanced fluid therapy
(OR 3.87), lack of early mobilization (OR 20.74), pro-
longed urinary catheterization (OR 4.58) and use of drai-
nage (OR 2.86) were significantly associated with
prolonged LOS. Neither traditional patient risk factors nor
the stage of the cancer was predictive of the duration of
hospital stay. Instead, compliance with the ERAS protocol
seems to influence recovery and LOS when applied to
laparoscopic colorectal cancer surgery.
Keywords Enhanced recovery after surgery  Fast-track
surgery  Laparoscopy  Perioperative care  Compliance
with protocol  Colorectal cancer
Introduction
Perioperative care programs in elective colorectal surgery
based on Enhanced Recovery After Surgery (ERAS)
Society recommendations have been shown to reduce the
length of hospital stay (LOS) and lower the complication
rate in colorectal surgery [1–4]. Some elements of the
protocol, such as balanced fluid therapy, multimodal
analgesia, metabolic management including early oral
feeding and early mobilization, have been reported as the
ones with specific importance [4, 5]. When these elements
are implemented, the reduction in the recovery time to a
median LOS as short as 2–3 days for open colonic resec-
tions was noted [6, 7]. However, the commonly reported
stays within an ERAS protocol are reduced from 9–10 to
5–6 days [3, 8–10]. In addition, the use of the laparoscopic
technique in ERAS has been shown to lead to even faster
recovery, decreased complication rate and shorter LOS in
most studies [8, 9, 11], but not in all cases [12]. Better
optimization of the ERAS pathway together with adequate
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organizational arrangements at the hospital, combined with
laparoscopic surgery, allows a further reduction in stay
down to 1 day in a selected group of patients [13].
However, the goal of modern perioperative care is not
primarily to minimize the LOS but rather to improve the
quality of the recovery [14]. The improved and faster
recovery will also allow for earlier discharges from hos-
pitals. However, very short postoperative hospital stay may
result in more readmissions. In the early work of Kehlet
readmission after ultra-short stays was as high as 20 %
[15]. Later research showed that improved adherence to
ERAS protocols resulted in fewer readmissions despite
shorter stay after open elective colorectal surgery [3].
Nevertheless, later data also showed that using ERAS fully
or just using more ERAS elements as assembled in several
meta-analyses since 2010 results in fewer complications
and shorter stays in hospital [3, 4, 11, 16, 17].
Minimally invasive techniques offer less surgically
induced trauma and influence other postoperative care ele-
ments [18]. Most of studies focus on short-term outcomes
such as LOS, complications and readmissions [8, 19]. So
far, little is known whether the combination of ERAS and
minimally invasive surgery impacts also the influence of
traditional risk factors on short-term surgical outcomes.
According to previously published analyses, such combi-
nation may indeed diminish the negative effect of some
demographic parameters (age, comorbidities, ASA grade)
in postoperative period [20]. However, this topic is still less
studied and therefore requires further investigation.
Aim
The aim of the current pilot study was to analyze factors
affecting recovery and length of stay in patients after
laparoscopic colorectal surgery for cancer treated accord-
ing to the protocol based on the ERAS Society guidelines
[1, 2].
Materials and methods
The analysis included prospectively collected data from
consecutive patients electively operated for colorectal
cancer in the years 2013–2014. During this time, the
standard primary surgical approach at the unit was that all
elective patients were operated using laparoscopic surgery,
and the perioperative care was based on preestablished
ERAS protocol consisting of 16 items (Table 1). Its prin-
ciples and criteria for discharge from the hospital were
based on the ERAS Society guidelines [21, 22].
Patients submitted initially for open or emergency sur-
gery or those with complex cancer who required
multiorgan resection, and patients treated with endoscopic
techniques using the hybrid TaTME technique were
excluded from the studied group.
During the time period of the study, a total of 176
patients with colorectal cancer were operated in the
department. Twenty-four patients did not meet inclusion
criteria. Out of the remaining 152 patients, 12 were con-
verted. The reasons for conversion were tumor infiltration
to surrounding organs (nine cases that were excluded from
the analysis) or other technical difficulties (three cases that
were included in the intention to treat analysis). Overall
143 patients (68 women and 75 men) underwent laparo-
scopic resections (Fig. 1).
Their mean age was 66.8 years (27–94 years). One
hundred patients underwent colonic resection, and 43 had
rectal resection. The demographic analysis of the group is
shown in Table 2.
We analyzed the influence of the following factors on
LOS (primary length of stay, excluding readmissions):
gender; age; BMI; ASA (American Society of Anaesthe-
siologists), physical status; the presence of preoperative
comorbidities; type of surgery (colonic resection vs. rectal
resection with total mesorectal excision, TME); stage of
cancer; distance between the hospital and place of resi-
dence; operative time; and intraoperative blood loss.
Moreover, the compliance with ERAS protocol was also
analyzed, taking into consideration its selected items:
mechanical bowel preparation, preoperative carbohydrate
loading (CHO loading), balanced fluid therapy (\2500 ml
intravenous fluids), early mobilization on the day of sur-
gery (all patients are actively encouraged by nursing staff
to be mobile), early introduction of oral feeding—each
patient received an oral nutritional supplement in the
afternoon on the day of the surgery and light hospital diet
on the first postoperative day followed by a full diet on the
second postoperative day, use of drains, prolonged ([24 h)
urinary catheterization and use of opioids (administered
only if the standard regimen was not sufficient). Compli-
ance was calculated as the number of pre- and intraoper-
ative interventions fulfilled/13 (number of protocol
elements included) similarly to Gustafsson [3]. Addition-
ally, we analyzed the rate of postoperative complications
and the readmission rate.
A standardized anesthetic protocol was used in all
patients: Antimicrobial prophylaxis (cefuroxime 1.5 g iv.
and metronidazole 0.5 g iv.) was administered 30–60 min
prior the first incision. Following preoxygenation, patients
were given fentanyl, 200–500 mcg iv. General anesthesia
was induced with propofol, 100–300 mg iv. Tracheal
intubation was facilitated with rocuronium. General anes-
thesia was maintained with sevoflurane and fentanyl
(100 mcg bolus every 30 min). Rocuronium was used for
muscle relaxation. Perioperatively, patients received
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postoperative nausea and vomiting prophylaxis (dexam-
ethasone, ondansetron). Colonic or rectal resections were
performed laparoscopically according to all oncological
principles as described elsewhere [23]. Complications were
graded using the Clavien–Dindo classification [24].
Readmission was defined as any patient hospitalization
related to the surgery within 30 days after being discharged
home.
The study obtained the ethical approval from the local
ethics review committee and has been performed in
Table 1 ERAS protocol used in our department
1. Preoperative counseling and patient’s education
2. No bowel preparation (oral lavage in the case of low rectal resection with TME and defunctioning loop ileostomy)
3. Preoperative carbohydrate loading (400 ml of Nutricia preOp 2 h prior surgery)
4. Antithrombotic prophylaxis (Clexane 40 mg sc. starting in the evening prior surgery)
5. Antibiotic prophylaxis (preoperative cefuroxime 1.5 g ? metronidazole 0.5 g iv. 30–60 min prior surgery)
6. Laparoscopic surgery
7. Balanced intravenous fluid therapy (\2500 ml intravenous fluids during the day of surgery,\150 mmol sodium)
8. No nasogastric tubes postoperatively
9. No drains left routinely for colonic resections, one drain placed for\24 h in case of TME
10. TAP block and standard anesthesia protocol
11. Avoiding opioids, multimodal analgesia (oral when possible—paracetamol 4 9 1 g, ibuprofen 2 9 200 mg, metamizole 2 9 500 mg or
ketoprofen 2 9 100 mg)
12. Prevention of postoperative nausea and vomiting (PONV) (dexamethasone 8 mg iv., ondansetron 8 mg iv., metoclopramide 10 mg iv.)
13. Postoperative oxygenation therapy (4–6 l/min)
14. Early oral feeding (oral nutritional supplement 4 h postoperatively—Nutricia Nutridrink or Nestlé Impact, light hospital diet and oral
nutritional supplements on the first postoperative day, full hospital diet in the second postoperative day)
15. Urinary catheter removal on the first postoperative day
16. Full mobilization on the first postoperative day (getting out of bed, going to toilette, walking along the corridor, at least 4 h out of bed)
Excluded  (n= 24)
- initially open surgery confirmed extensive  (n=5)
infiltration to surrounding organs (n=4)
history of numerous laparotomies (n=1) 
- emergency cases (n=9)
- TaTME and endoscopic removal (n= 10 )
Submitted to laparoscopy (n=152)
Excluded  (n= 9)
multiple organ resection (converted) (n= 9)
Intention To Treat analysis (n= 143)
laparoscopic surgery (n= 140)
converted to open procedure (n= 3)
Assessed for eligibility (n= 176)
Fig. 1 Patient ITT flowchart
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accordance with the ethical standards laid down in the 1964
Declaration of Helsinki and its later amendments. It was
registered under NCT02527967 (ClinicalTrials.gov).
Informed consent was obtained from all patients before
surgery.
StatSoft Statistica v.10 was used for statistical analysis.
For the purposes of further analyses, the entire group of
patients was divided into two subgroups depending on the
length of their hospital stay. On admission, every patient
received the information about the target length of stay of
4 days. Group 1 consisted of patients whose hospital stay
was shorter or equal to the target LOS (B4 days). In group
2 were patients whose hospital stay was longer than 4 days.
Additionally, the entire group of patients was divided
according to occurrence of complications. The study of
categorical variables used the Chi-square test of indepen-
dence. In the case of non-normally distributed quantitative
variables, Mann–Whitney U test was used. An univariate
logistic regression analysis of individual demographic and
perioperative parameters was undertaken to assess factors
influencing prolonged LOS as well as occurrence of com-
plications. Finally, the variables in the univariate logistic
regression analysis that had a significant impact on the
length of hospital stay were used to build a multivariate
logistic regression model. Results were considered statis-
tically significant when p value was found to be\0.05.
Results
The median length of hospital stay in the entire group was
4 days, and this was the planned LOS before the study was
initiated. Therefore, two subgroups were created (cutoff
LOS 4 days) for the purpose of further statistical analyses.
The analysis of demographic parameters (including the
location and stage of cancer as well as type of surgery and
Table 2 Demographic analysis of patient groups
Parameter All patients Group 1 (B4 days) Group 2 ([4 days) p value
Number of patients, n (%) 143 75 (52.4 %) 68 (47.6 %) –
Females, n (%) 68 (47.6 %) 39 (52 %) 29 (42.6 %) 0.26
Males, n (%) 75 (52.4 %) 36 (48 %) 39 (57.4 %)
Mean age, years ± SD 66.8 ± 12.6 65.9 ± 12.9 67.3 ± 12.3 0.35
BMI, kg/m2 ± SD 25.9 ± 4.9 26.5 ± 5.3 25.2 ± 4.5 0.24
ASA 1, n (%) 5 (3.5 %) 4 (5.3 %) 1 (1.5 %) 0.14
ASA 2, n (%) 87 (60.9 %) 44 (58.7 %) 43 (63.2 %)
ASA 3, n (%) 47 (32.8 %) 23 (30.7 %) 24 (35.3 %)
ASA 4, n (%) 4 (2.8 %) 4 (5.3 %) 0 (0 %)
Any comorbidity, n (%) 109 (76.2 %) 54 (72.0 %) 55 (80.9 %) 0.21
Cardiovascular, n (%) 52 (36.4 %) 25 (33.3 %) 27 (39.7 %) 0.92
Hypertension, n (%) 74 (51.7 %) 39 (52.0 %) 35 (51.5 %) 0.95
Diabetes, n (%) 28 (19.6 %) 15 (20 %) 13 (19.1 %) 0.89
Pulmonary, n (%) 21 (14.7 %) 9 (12.0 %) 12 (17.6 %) 0.34
Renal, n (%) 12 (8.4 %) 7 (9.3 %) 5 (7.4 %) 0.67
Liver, n (%) 5 (3.5 %) 1 (1.3 %) 4 (5.9 %) 0.14
Distance from the place of residence\50 km, n (%) 103 (72 %) 52 (69.3 %) 51 (75.0 %) 0.33
Distance from the place of residence[50 km, n (%) 40 (28 %) 23 (30.1 %) 17 (25.0 %)
Colonic resection, n (%) 100 (69.9 %) 56 (74.7 %) 44 (64.7 %) 0.19
TME, n (%) 43 (30.1 %) 19 (25.3 %) 24 (35.3 %) 0.50
AJCC Stage I, n (%) 45 (31.5 %) 27 (36 %) 18 (26.5 %)
AJCC Stage II, n (%) 49 (34.2 %) 26 (34.7 %) 23 (33.8 %)
AJCC Stage III, n (%) 34 (23.8 %) 16 (21.3 %) 18 (26.5 %)
AJCC Stage IV, n (%) 15 (10.5 %) 6 (8 %) 9 (13.2 %)
Mean length of hospital stay, days (range) 5.5 (2–40) 2.9 (2–4) 8.4 (5–40) –
Median length of hospital stay, days (IQR) 4 (3–7) 3 (2–3) 7 (5–8) –
Mean operative time, min ± SD 185.1 ± 62.2 185.4 ± 51.3 184.8 ± 73.8 0.49
Mean intraoperative blood loss, ml ± SD 90.2 ± 79.5 84.3 ± 74.1 97 ± 86.1 0.36
Conversion, n (%) 3 (2.1 %) 0 3 (4.4 %) –
AJCC American Joint Committee on Cancer, ASA American Society of Anaesthesiologists, SD standard deviation, IQR interquartile range
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comorbidities) showed no significant differences between
groups as presented in Table 2. In contrast, we have found
some differences in the use of pre- and intraoperative
ERAS protocol items (Table 3). Moreover, there was also a
significant difference in overall compliance with the pro-
tocol (91.2 ± 9.6 vs. 76.7 ± 13.6, p = 0.00001).
Complications
The overall complication rate was 27.3 % (18.7 vs. 36.8 %
in group 1 and 2, p = 0.02). They are summarized in
Table 4. We observed a significant difference in compli-
ance between patients with and without complications
when calculated for the entire group (86.5 vs. 79.1 %,
p = 0.005). Readmission occurred in eight (5.6 %) patients
(six patients in group 1 and two patients in group 2,
p = 0.19). Using univariate regression analysis, we
observed that only bowel preparation (OR 3.15, 95 % CI
1.45–6.86, p = 0.004) and non-balanced fluid therapy (OR
2.99, 95 % CI 1.28–6.96, p = 0.012) were independent
predictors of complications in our group. The remaining
parameters such as: CHO loading (OR 1.49, 95 % CI
0.68–3.27, p = 0.31), tolerance of full oral diet in the first
postoperative day (OR 1.71, 95 % CI 0.79–3.72,
p = 0.17), mobilization on the day of surgery (OR 1.29,
95 % CI 0.50–3.29, p = 0.6), peritoneal drainage (OR
1.35, 95 % CI 0.63–2.92, p = 0.44), prolonged urinary
catheterization (OR 1.43, 95 % CI 0.55–3.73, p = 0.46),
type of surgery (OR 1.79, 95 % CI 0.82–3.94, p = 0.14),
use of opioids (OR 0.94, 95 % CI 0.43–2.08, p = 0.88) as
well as sex (OR 1.01, 95 % CI 0.47–2.18, p = 0.98), age
(OR 0.86, 95 % CI 0.41–1.84, p = 0.7), comorbidities (OR
1.23, 95 % CI 0.5–3.05, p = 0.65) and stage of disease
(OR 0.72, 95 % CI 0.19–2.78, p = 0.62) had no influence
on complications. Since only two parameters were statis-
tically significant in univariate logistic regression analysis,
we decided not to follow with the multivariate logistic
regression model.
Comorbidities
One hundred and nine (76.2 %) patients had at least one
comorbidity. There were no differences in the types of
comorbidity between groups 1 and 2. We did not observe
any influence of the presence of one or more comorbidities
on LOS or complications except for the presence of car-
diovascular disease that was significantly more prevalent in
the patients without complications (Table 5).
Length of stay
In the current patient group, age, gender, ASA, BMI,
presence of comorbidities, distance from the place of res-
idence, cancer stage, presence of a stoma or use of opioids
had no effect on primary length of hospital stay. In the
univariate logistic regression analysis, it was found, how-
ever, that presence of postoperative complications, bowel
preparation, lack of CHO loading, non-balanced fluid
therapy, poor tolerance of early oral diet, lack of mobi-
lization on the day of surgery, peritoneal drainage, [24-h
urinary catheterization, were all related to prolonged LOS
(Table 6).
In turn, the multivariate logistic regression model (R2
Nagelkerke coefficient of determination = 0.46) only fluid
overload, lack of mobilization on the day of surgery, pro-
longed ([24 h) urinary catheterization and peritoneal
drainage remained significant factors prolonging LOS
(Table 6).
Discussion
In this pilot study of patients undergoing laparoscopic
colorectal resections combined with the ERAS protocol,
we found that many of the traditional demographic factors
such as age, comorbidity, ASA stage seem to have little or
no impact on short-term outcomes. When using the
Table 3 Perioperative parameters in analyzed groups
Parameter Group 1 (B4 days) Group 2 ([4 days) p value
Mechanical bowel preparation, n (%) 25 (33.3 %) 36 (52.9 %) 0.02
Preoperative CHO loading, n (%) 58 (77.3 %) 37 (54.4 %) 0.006
Balanced fluid therapy, n (%) 69 (92 %) 42 (61.8 %) 0.00002
Peritoneal drainage, n (%) 14 (18.7 %) 38 (55.9 %) 0.00001
Prolonged ([24 h) catheterization after surgery, n (%) 5 (6.7 %) 19 (27.9 %) 0.0003
Stoma formation, n (%) 8 (10,6 %) 14 (20.6 %) 0.10
Postoperative use of opioids, n (%) 26 (34.7 %) 27 (39.7 %) 0.40
Tolerance of full oral diet in the first postoperative day, n (%) 58 (77.3 %) 37 (54.4 %) 0.005
Mobilization on the day of the surgery, n (%) 74 (98.6 %) 42 (61.8 %) 0.00001
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multivariate regression model adjusted for the type of
surgery, we observed that it was a low compliance with
perioperative ERAS care elements that prolonged LOS
rather than factors traditionally reported to prolong recov-
ery. The study showed that if the patients were not mobi-
lized on the day of surgery, received non-balanced fluid
therapy, had prolonged catheterization or peritoneal drai-
nage, they also stayed longer in the hospital. When com-
paring the patients leaving within target LOS of 4 days
with those staying longer, it was found that overall dif-
ferences in compliance with the ERAS protocol and several
of the single elements as well as complication rates differed
between these two patient groups. Similar to several pre-
vious reports, we also found an association between ERAS
protocol compliance and complications [3, 9].
In contrast, we failed to demonstrate any influence of
demographic parameters and classical risk factors on the
development of complications. This is likely to be
explained by the low level of stress inflicted when the
stress reducing protocol elements of the ERAS protocol
and laparoscopic surgery is combined [25]. In this study,
we did not investigate potential mechanisms behind this
finding. However, previous studies suggest that reducing
the stress response to surgery, minimizing the inflamma-
tory responses, controlling pain relief and retaining
homeostasis for metabolism and fluid balance are all likely
to contribute to the finding that these classical risk factors
are of less importance [26–29].
Our study group consisted of consecutive cases sub-
mitted to minimally invasive colorectal resection in an
ERAS environment. Although laparoscopy is gaining
momentum and the rate of these procedures increases
worldwide, the data comprising only laparoscopic cases in
ERAS are sparse. According to Khan et al., no further
benefit is obtained by the inclusion of laparoscopic surgery
in ERAS protocols. However, the evidence was limited
[30]. In 2011, Vlug et al. [8] published the first randomized
controlled trial, showing that in ERAS environment
laparoscopic surgery can indeed bring benefits such as
shorter LOS and reduced morbidity. It was later confirmed
by Kennedy et al. [19] in EnROL trial. However, most of
the current studies in large bowel surgery comprise
heterogeneous groups of both open and laparoscopic pro-
cedures or open series only. The conversion rate of 2.1 %
is relatively low comparing to other studies on laparoscopic
surgery [20, 31–34]. The mean LOS (5.5 days) as well as
the complication rate (27.3 %) of the entire group reported
in this study is in line with previously published groups
[35–37].
The mean overall compliance with the ERAS protocol
of 83 % is similar if not higher than presented in other
studies [3, 20, 32]. The link between the adherence to the
Table 4 Types of complications in both groups
Clavien–Dindo
classification
Complications Group 1 (B4 days) Group 2 ([4 days) p value
III B Perforation of transverse colon
from Veress needle
(relaparoscopy, suturing)
0/14 (0 %) 3 (4.0 %) 1/25 (4 %) 6 (8.8 %) 0.51
Perforation of small intestine
(relaparotomy, resection)
0/14 (0 %) 1/25 (4 %)
Peristomal fistula (correction
under general anesthesia)
0/14 (0 %) 1/25 (4 %)
Trocar-related abdominal wall
bleeding (relaparoscopy)
1/14 (7 %) 0/25 (0 %)
III A Bleeding from anastomosis suture
line (controlled endoscopically)
2/14 (14 %) 0/25 (0 %)
Anastomosis leakage (treated with
Endo-SPONGE)
0/14 (0 %) 3/25 (12 %)
II Intraperitoneal hematoma 0/14 (0 %) 1 (1.3 %) 1/25 (4 %) 5 (7.3 %)
Infectious diarrhea (C. difficile) 0/14 (0 %) 1/25 (4 %)
Pneumonia 0/14 (0 %) 1/25 (4 %)
Urinary tract infection 1/14 (7 %) 2/25 (8 %)
I Surgical site infection 3/14 (22 %) 10 (13.3 %) 5/25 (20 %) 14 (20.6 %)
Non-infectious diarrhea 1/14 (7 %) 0/25 (0 %)
Postoperative nausea and vomiting 5/14 (36 %) 7/25 (28 %)
Arrhythmia 1/14 (7 %) 1/25 (4 %)
Postoperative confusion 0/14 (0 %) 1/25 (4 %)
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protocol and outcomes was extensively studied by
Gustafsson [3] in open colorectal resections, who showed
that improving compliance may result in reducing post-
operative morbidity and thus shortening of LOS. Our
results in laparoscopic resections are consistent with these
observations. We found that compliance in group 1 was
significantly higher than in group 2 with longer stay. This
supports the notion that the length of hospital stay is
influenced by pre- and intraoperative ERAS parameters.
These are also the treatment choices that are mostly
influenced by the team treating the patient, and to a lesser
extent dependent on patient factors.
Perhaps the most interesting finding in this group of
patients was that none of the classical demographic
parameters analyzed had any effect on prolonged hospi-
talization. Thus, neither age and comorbidities nor ASA
grade had any impact on length of stay or complications.
Similar conclusions were drawn by Smart et al. [20] in
laparoscopic colorectal surgery. Our observation, however,
is in contrary to those presented in other studies comprising
patients undergoing open or minimally invasive colorectal
resection. Hendry reported that age, male sex and rectal
surgery influenced LOS [38]. Although most studies found
that serious comorbidities (ASA III–IV) are indeed a risk
factor for worse outcomes, the link between the presence,
number as well as their types and complication rate or
prolonged LOS was not confirmed in our analysis [35, 38,
39]. In large series from Denmark employing ERAS
Table 5 Comorbidities and
their relation to length of stay
and complications
Length of stay
All patients Group 1 (B4 days) Group 2 ([4 days) p value
Comorbidity
Any comorbidity 109 (76.2 %) 54 (72.0 %) 55 (80.9 %) 0.21
Cardiovascular 52 (36.4 %) 25 (33.3 %) 27 (39.7 %) 0.92
Hypertension 74 (51.7 %) 39 (52.0 %) 35 (51.5 %) 0.95
Diabetes 28 (19.6 %) 15 (20 %) 13 (19.1 %) 0.89
Pulmonary 21 (14.7 %) 9 (12.0 %) 12 (17.6 %) 0.34
Renal 12 (8.4 %) 7 (9.3 %) 5 (7.4 %) 0.67
Liver 5 (3.5 %) 1 (1.3 %) 4 (5.9 %) 0.14
Number of comorbidities
0 34 (23.8 %) 21 (28.0 %) 13 (19.1 %) 0.58
1 58 (40.5 %) 27 (36.0 %) 31 (45.6 %)
2 24 (16.8 %) 13 (17.4 %) 11 (16.2 %)
3 23 (16.1 %) 12 (16.0 %) 11 (16.2 %)
4 3 (2.1 %) 1 (1.3 %) 2 (2.9 %)
5 1 (0.7 %) 1 (1.3 %) 0
Complications
All patients Without complications With complications p value
Parameter
Any comorbidity 109 (76.2 %) 79 (76.0 %) 30 (76.9 %) 0.90
Cardiovascular 52 (36.4 %) 43 (41.3 %) 9 (23.1 %) 0.04
Hypertension 74 (51.7 %) 53 (51.0 %) 21 (53.8 %) 0.76
Diabetes 28 (19.6 %) 20 (19.2 %) 8 (20.5 %) 0.86
Pulmonary 21 (14.7 %) 18 (17.3 %) 3 (7.7 %) 0.13
Renal 12 (8.4 %) 11 (10.6 %) 1 (2.6 %) 0.09
Liver 5 (3.5 %) 4 (3.9 %) 1 (2.6 %) 0.70
Number of comorbidities
0 34 (23.8 %) 25 (24.0 %) 9 (23.1 %) 0.26
1 58 (40.5 %) 37 (35.6 %) 21 (53.8 %)
2 24 (16.8 %) 19 (18.3 %) 5 (12.8 %)
3 23 (16.1 %) 19 (18.3 %) 4 (10.3 %)
4 3 (2.1 %) 3 (2.9 %) 0
5 1 (0.7 %) 1 (0.9 %) 0
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methodology in hip and knee replacement, it was showed
that age is less of a factor for length of stay and even
patients older than 85 years have a median stay of 4 days
[40]. The same group also showed that major risk factors
such as diabetes have much less impact, if any, with
modern enhanced recovery care [41].
In a recent study from the ERAS Compliance Group,
balanced fluid therapy was one of the strongest factors
influencing postoperative outcomes [9]. The benefits of
appropriate fluid management have been shown repeatedly
[42–45]. In our study, not maintaining balanced fluid
therapy was associated with an almost four times higher
risk of prolonged stay and higher complication rates. In
62.9 % of all patients, fluids were stopped within 24
postoperatively. It was in 70.7 % patients from group 1 and
in 54.4 % from group 2. According to our protocol, we do
not continue infusions postoperatively when not needed.
Prolonged intravenous fluid therapy was mostly due to
inability to tolerate oral fluids (complications such as
PONV, ileus). However, in some patients, we had to come
back to iv. fluids in subsequent days due to delayed
recovery of the gastrointestinal function.
Several studies have shown that keeping high compli-
ance with the ERAS protocol results in a reduction in
morbidity [3, 9, 46]. We found that certain factors were of
specific importance for the time of recovery. Tolerating
diet on the day of surgery was one of them. An attempt to
introduce an oral diet on the day of the surgery was made
in all patients, tolerating early feeding was much better in
the group that managed early discharge compared to those
with longer stay (77.3 vs. 55.4 %, p = 0.0051). Not tol-
erating early feeding was associated with prolonged stay.
Mobilization on the day of surgery was another factor that
affected recovery time. Gustafsson et al. [47] made the
comparison of open and laparoscopic rectal surgery in
terms of early mobilization within an ERAS protocol and
showed benefits of the latter. All patients in the group with
early discharge (with the exception of one patient who
initially was on the wheelchair) were mobilized on the day
of surgery. In contrast, in group 2 only 60 % of patients
were ambulated. As mentioned above, while early oral diet
tolerance and mobilization may be regarded as outcomes
and result of care given earlier during the patients pathway,
they can serve as early predictors of delayed recovery [20,
34, 48].
In hospitals where ERAS protocol is fully imple-
mented, mean LOS can be shortened to 1–4 days in select
groups of patients [13, 37]. In this situation, any compli-
cation will inevitably lead to longer hospital stay. Our
observations are consistent with the findings of other
authors in this respect [34, 35, 39, 49]. In the group
keeping to short LOS complications were mostly Clavien–
Dindo grade 1, and all but one case were treated conser-
vatively. These problems had minimal impact on recovery
and did not necessarily prolong hospitalization. In con-
trast, the prolonged length of stay in the delayed discharge
group was explained to a large extent by the more severe
types of complications. However, when they were inclu-
ded in the multivariate model, they were not significant
predictors of prolonged LOS. The relatively small group
of patients with complications and the fact that there were
also other factors that had greater impact on outcomes
may explain this divergence between uni- and multivariate
logistic regression analysis. In this group, there were more
complex problems and many complications deemed either
another surgical/endoscopic intervention or longer con-
servative treatment.
The data in the literature on the location and stage of
cancer influencing LOS are contradictory [20, 35, 38, 39,
50–52]. In our analysis, the percentage of patients with
rectal cancer in group 2 was indeed greater, although the
difference was not significant. It is reasonable to assume
that the type of surgery (colonic or rectal) influenced out-
comes to some extent, and for that reason, this was
Table 6 Uni- and multivariate logistic regression analysis (adjusted for type of surgery colon/rectum) of the parameters affecting prolonged
hospitalization (R2 Nagelkerke = 0.46)
Parameter Univariate logistic regression Multivariate logistic regression
OR 95 % CI p value OR 95 % CI p value
Mechanical bowel preparation 2.25 1.14–4.45 0.02 1.14 0.42–3.11 0.79
No preoperative CHO loading 2.75 1.32–5.73 0.007 1.23 0.41–3.66 0.70
Non-balanced fluid therapy 6.85 2.57–18.21 0.00015 3.87 1.02–14.71 0.046
Peritoneal drainage 5.62 2.62–12.04 0.00001 2.86 1.01–8.14 0.048
Prolonged ([ 24 h) catheterization 5.57 1.92–16.17 0.002 4.58 1.33–15.74 0.02
Tolerating oral diet on the first postoperative day 2.77 1.33–5.74 0.007 1.01 0.33–3.10 0.99
Mobilization on the day of surgery 45.81 5.89–356.12 0.0003 20.74 2.25–191.30 0.008
Postoperative complications 2.38 1.10–5.14 0.03 2.00 0.72–5.59 0.18
Colon/rectum 1.61 0.78–4.32 0.19 1.15 0.37–3.56 0.81
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included in the analysis and showed no impact. Although it
has been previously shown that the stage of cancer influ-
ences LOS in open surgery with traditional care, we were
unable to confirm such relationship in our laparoscopic
group with ERAS protocol [53]. In our model, we were
able to explain almost 50 % of the variation in length of
stay with the factors identified. This is a reasonable level,
but there remain many factors to be taken into account to
understand the entire picture. One such factor that we did
not study was the capacity of the receiving end that is the
care or support at home or availability of the caretakers
after discharge.
Conclusions
Our observations in patients undergoing laparoscopic col-
orectal surgery in an ERAS environment indicate that
delayed recovery and prolonged hospital stay are associ-
ated with lack of compliance with some ERAS protocol
elements such as maintaining fluid balance, mobilization
postoperatively as well as remaining catheters and drains,
and the development of complications. In this context,
patient demographic characteristics, comorbidities, anes-
thetic risk or stage of the disease was not predictive of the
duration of hospital stay or development of complications.
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33. Alcántara-Moral M, Serra-Aracil X, Gil-Egea MJ, Frasson M,
Flor-Lorente B, Garcia-Granero E, et al. Observational cross-
sectional study of compliance with the fast track protocol in
elective surgery for colon cancer in Spain. Int J Colorectal Dis.
2014;29:477–83.
34. Boulind CE, Yeo M, Burkill C, Witt A, James E, Ewings P, et al.
Factors predicting deviation from an enhanced recovery pro-
gramme and delayed discharge after laparoscopic colorectal
surgery. Colorectal Dis. 2012;14:e103–10.
35. Keller DS, Bankwitz B, Woconish D, Champagne BJ, Reynolds
HL, Stein SL, et al. Predicting who will fail early discharge after
laparoscopic colorectal surgery with an established
enhanced recovery pathway. Surg Endosc. 2013;28:74–9.
36. Scala A, Huang A, Dowson HMP, Rockall TA. Laparoscopic
colorectal surgery—results from 200 patients. Colorectal Dis.
2007;9:701–5.
37. Delaney CP. Outcome of discharge within 24 to 72 hours after
laparoscopic colorectal surgery. Dis Colon Rectum. 2008;51:181–5.
38. Hendry PO, Hausel J, Nygren J, Lassen K, Dejong CHC,
Ljungqvist O, et al. Determinants of outcome after colorectal
resection within an enhanced recovery programme. Br J Surg.
2009;96:197–205.
39. Ahmed J, Lim M, Khan S, McNaught C, MacFie J. Predictors of
length of stay in patients having elective colorectal surgery within
an enhanced recovery protocol. Int J Surg. 2010;8:628–32.
40. Jørgensen CC, Kehlet H, Lundbeck Foundation Centre for Fast-
track Hip and Knee Replacement Collaborative Group. Role of
patient characteristics for fast-track hip and knee arthroplasty. Br
J Anaesth. 2013;110:972–80.
41. Jørgensen CC, Madsbad S, Kehlet H, Lundbeck Foundation
Centre for Fast-track Hip and Knee Replacement Collaborative
Group. Postoperative morbidity and mortality in type-2 diabetics
after fast-track primary total hip and knee arthroplasty. Anesth
Analg. 2015;120:230–8.
42. Varadhan KK, Lobo DN. A meta-analysis of randomised con-
trolled trials of intravenous fluid therapy in major elective open
abdominal surgery: getting the balance right. Proc Nutr Soc.
2010;69:488–98.
43. Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ,
Allison SP. Effect of salt and water balance on recovery of
gastrointestinal function after elective colonic resection: a ran-
domised controlled trial. Lancet. 2002;359:1812–8.
44. Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding
H, Lindorff-Larsen K, et al. Effects of intravenous fluid restric-
tion on postoperative complications: comparison of two periop-
erative fluid regimens. Ann Surg. 2003;238:641–8.
45. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A
rational approach to perioperative fluid management. Anesthesi-
ology. 2008;109:723–40.
46. Vlug MS, Bartels SAL, Wind J, Ubbink DT, Hollmann MW,
Bemelman WA, et al. Which fast track elements predict early
recovery after colon cancer surgery?ColorectalDis. 2012;14:1001–8.
47. Gustafsson UO, Tiefenthal M, Thorell A, Ljungqvist O, Nygrens
J. Laparoscopic-assisted and open high anterior resection within
an ERAS protocol. World J Surg. 2012;36:1154–61.
48. Vlug MS, Bartels SAL, Wind J, Ubbink DT, Hollmann MW,
Bemelman WA, et al. Which fast track elements predict early
recovery after colon cancer surgery?ColorectalDis. 2012;14:1001–8.
49. Kiran RP, Delaney CP, Senagore AJ, Steel M, Garafalo T, Fazio
VW. Outcomes and prediction of hospital readmission after
intestinal surgery. ACS. 2004;198:877–83.
50. Kahokehr AA, Sammour T, Sahakian V, Zargar-Shoshtari K, Hill
AG. Influences on length of stay in an enhanced recovery pro-
gramme after colonic surgery. Colorectal Dis. 2011;13:594–9.
51. Faiz O, Haji A, Burns E, Bottle A, Kennedy R, Aylin P. Hospital
stay amongst patients undergoing major elective colorectal sur-
gery: predicting prolonged stay and readmissions in NHS hos-
pitals. Colorectal Dis. 2011;13:816–22.
52. Tartter PI. Determinants of postoperative stay in patients with
colorectal cancer. Implications for diagnostic-related groups. Dis
Colon Rectum. 1988;31:694–8.
53. Perng D-S, Lu I-C, Shi H-Y, Lin C-W, Liu K-W, Su Y-F, et al.
Incidence trends and predictors for cost and average lengths of
stay in colorectal cancer surgery. World J Gastroenterol.
2014;20:532–8.
25 Page 10 of 10 Med Oncol (2016) 33:25
123
